385 related articles for article (PubMed ID: 15907581)
1. Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.
Aliabadi HM; Mahmud A; Sharifabadi AD; Lavasanifar A
J Control Release; 2005 May; 104(2):301-11. PubMed ID: 15907581
[TBL] [Abstract][Full Text] [Related]
2. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution.
Aliabadi HM; Brocks DR; Lavasanifar A
Biomaterials; 2005 Dec; 26(35):7251-9. PubMed ID: 16005061
[TBL] [Abstract][Full Text] [Related]
3. Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading.
Aliabadi HM; Elhasi S; Mahmud A; Gulamhusein R; Mahdipoor P; Lavasanifar A
Int J Pharm; 2007 Feb; 329(1-2):158-65. PubMed ID: 17008034
[TBL] [Abstract][Full Text] [Related]
4. Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin.
Ma Z; Haddadi A; Molavi O; Lavasanifar A; Lai R; Samuel J
J Biomed Mater Res A; 2008 Aug; 86(2):300-10. PubMed ID: 17957721
[TBL] [Abstract][Full Text] [Related]
5. The effect of block copolymer structure on the internalization of polymeric micelles by human breast cancer cells.
Mahmud A; Lavasanifar A
Colloids Surf B Biointerfaces; 2005 Oct; 45(2):82-9. PubMed ID: 16144761
[TBL] [Abstract][Full Text] [Related]
6. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
7. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells.
Xiong XB; Mahmud A; Uludağ H; Lavasanifar A
Biomacromolecules; 2007 Mar; 8(3):874-84. PubMed ID: 17315946
[TBL] [Abstract][Full Text] [Related]
8. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery.
Shahin M; Lavasanifar A
Int J Pharm; 2010 Apr; 389(1-2):213-22. PubMed ID: 20080163
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery.
Xiong XB; Uludağ H; Lavasanifar A
Biomaterials; 2009 Jan; 30(2):242-53. PubMed ID: 18838158
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of methoxy poly(ethylene oxide)-
Ali R; Farah A; Binkhathlan Z
Saudi Pharm J; 2017 Feb; 25(2):258-265. PubMed ID: 28344477
[TBL] [Abstract][Full Text] [Related]
11. Self-associating poly(ethylene oxide)-b-poly(alpha-cholesteryl carboxylate-epsilon-caprolactone) block copolymer for the solubilization of STAT-3 inhibitor cucurbitacin I.
Mahmud A; Patel S; Molavi O; Choi P; Samuel J; Lavasanifar A
Biomacromolecules; 2009 Mar; 10(3):471-8. PubMed ID: 19175305
[TBL] [Abstract][Full Text] [Related]
12. A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers.
Aliabadi HM; Brocks DR; Mahdipoor P; Lavasanifar A
J Control Release; 2007 Sep; 122(1):63-70. PubMed ID: 17644207
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
Falamarzian A; Lavasanifar A
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
[TBL] [Abstract][Full Text] [Related]
14. Monolayer-protected gold nanoparticles by the self-assembly of micellar poly(ethylene oxide)-b-poly(epsilon-caprolactone) block copolymer.
Azzam T; Eisenberg A
Langmuir; 2007 Feb; 23(4):2126-32. PubMed ID: 17279704
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of Orally Administered Poly(Ethylene Oxide)-block-Poly(ε-Caprolactone) Micelles of Cyclosporine A in Rats: Comparison with Neoral®.
Binkhathlan Z; Ali R; Qamar W; Lavasanifar A
J Pharm Pharm Sci; 2018; 21(1s):192s-199s. PubMed ID: 30139426
[TBL] [Abstract][Full Text] [Related]
16. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors.
Molavi O; Ma Z; Mahmud A; Alshamsan A; Samuel J; Lai R; Kwon GS; Lavasanifar A
Int J Pharm; 2008 Jan; 347(1-2):118-27. PubMed ID: 17681440
[TBL] [Abstract][Full Text] [Related]
17. Solubilization of an amphiphilic drug by poly(ethylene oxide)-block-poly(ester) micelles.
Elhasi S; Astaneh R; Lavasanifar A
Eur J Pharm Biopharm; 2007 Mar; 65(3):406-13. PubMed ID: 17291732
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of polymeric micelles from brush polymer with poly(epsilon-caprolactone)-b-poly(ethylene glycol) side chains as drug carrier.
Du JZ; Tang LY; Song WJ; Shi Y; Wang J
Biomacromolecules; 2009 Aug; 10(8):2169-74. PubMed ID: 19722555
[TBL] [Abstract][Full Text] [Related]
19. Development of a polymeric micellar formulation for valspodar and assessment of its pharmacokinetics in rat.
Binkhathlan Z; Hamdy DA; Brocks DR; Lavasanifar A
Eur J Pharm Biopharm; 2010 Jun; 75(2):90-5. PubMed ID: 20332028
[TBL] [Abstract][Full Text] [Related]
20. Polymeric micelles based on poly(ethylene oxide) and α-carbon substituted poly(ɛ-caprolactone): An in vitro study on the effect of core forming block on polymeric micellar stability, biocompatibility, and immunogenicity.
Garg SM; Vakili MR; Lavasanifar A
Colloids Surf B Biointerfaces; 2015 Aug; 132():161-70. PubMed ID: 26037706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
